Evonik stock holds firm as Q2 revenue reaches €3.89 billion
Published on 08/22/2026 at 13:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Evonik Industries AG (DE000EVNK013) held at €18.38 on August 21, 2026, with a market value of €8.57 billion and a 2026 year-to-date gain of 36.89%. Q2 2026 revenue reached €3.89 billion, operating income was €483 million, and net income was €84 million.
Q2 numbers set the tone
The latest reported quarter showed revenue up 11.3% year over year to €3.89 billion, while gross profit came in at €962 million. Operating income improved to €483 million, and operating cash flow reached €204 million in Q2 2026.
For investors, the comparison matters: net income rose from €68 million in Q1 2026 to €84 million in Q2 2026, and the business generated €204 million in cash from operations in the same period.
Valuation stays in view
The share price of €18.38 leaves the stock below its recent market reaction peak, but the 36.89% 2026 gain shows how much ground it has already covered this year. The market cap of €8.57 billion gives the move a larger-cap profile than a simple short-term trade.
Revenue of €3.89 billion against a trailing-twelve-month figure of €14.11 billion also keeps the company in a scale bracket that supports segment-level swings rather than headline-only trading.
More on Evonik Industries AG
Evonik's business mix still centers on specialty chemicals, where demand, pricing, and plant utilization feed directly into margins and cash generation. The latest quarter's €483 million operating income suggests that operating discipline remains a central part of the story.
Evonik stock and the market view
Evonik stock traded at €18.38 on August 21, 2026, with a market cap of €8.57 billion and a 2026 year-to-date gain of 36.89%.
Company
Company: Evonik Industries AG
ISIN: DE000EVNK013
Ticker: EVK
Exchange: Xetra
Price (as of August 21, 2026): €18.38
Market cap: €8.57 billion
Sector / Industry: Materials / Specialty Chemicals
Index membership: MDAX
